Overview
I am striving to become a clinical and research leader in structural heart disease and complex coronary disease, specifically in the use of antithrombotic agents after structural heart interventions. I will also explore the significance of bleeding/vascular complications and stroke in these patients as well as potential therapies such as transfusion, and embolic protection devices.
Current Duke Appointments & Affiliations
Adjunct Assistant Professor in the Department of Medicine
·
2016 - Present
Medicine, Cardiology,
Medicine
Recent Scholarly Works
Delirium Among Adults Undergoing Transcatheter Structural Heart Intervention: Incidence, Risk, and Clinical Phenotypes.
Journal article Catheter Cardiovasc Interv · September 2026 BACKGROUND: Delirium is an underrecognized geriatric complication after transcatheter structural heart interventions, with limited descriptive data across procedures and an uncertain association with clinical outcomes. AIMS: To quantify incidence, identify ... Full text Link to item CiteIn it for the Long Run: Health Status as a Lifetime Metric in Low-Risk Aortic Stenosis.
Journal article J Am Coll Cardiol · August 17, 2026 Full text Link to item CiteHospital Volume and Failure to Rescue Post-TAVR: Insights From the STS/ACC TVT Registry.
Journal article JACC Cardiovasc Interv · July 13, 2026 BACKGROUND: There is an inverse volume-mortality relationship for transcatheter aortic valve replacement (TAVR), with higher adjusted mortality among hospitals with lower TAVR volumes. OBJECTIVES: The aim of this study was to identify potential mediators o ... Full text Link to item CiteEducation
Duke University ·
2014
M.H.S.
Emory University, School of Medicine ·
2006
M.D.